跳至主要内容
临床试验/NCT00540280
NCT00540280暂停3 期

Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer

King Faisal Specialist Hospital & Research Center0 个研究点目标入组 10 人开始时间: 2003年10月最近更新:
适应症

试验速览

阶段
3 期
状态
暂停
入组人数
10
主要终点
OS, MS, DFS

研究概览

简要总结

Randomized Phase III trial of surgery alone or surgery plus preoperative Gemcitabine-Cisplatin in clinical early stages of non-small cell lung cancer

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with early stage NSCLC

排除标准

  • 未提供

结局指标

主要结局

OS, MS, DFS

时间窗: overall

次要结局

未报告次要终点

研究者

相似试验

已完成
3 期
Randomized Phase III Trial Comparing surgery-alone to UFT+PSK in Stage II Rectal CancerRectal cancer
JPRN-UMIN000001527Japanese Foundation for Multidisciplinary Treatment of Cancer540
已完成
3 期
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract CancersStage III Distal Bile Duct Cancer AJCC v8Stage III Gallbladder Cancer AJCC v8Stage III Intrahepatic Cholangiocarcinoma AJCC v8Stage IIIA Distal Bile Duct Cancer AJCC v8Stage IIIA Gallbladder Cancer AJCC v8Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8Stage IIIB Distal Bile Duct Cancer AJCC v8Stage IIIB Gallbladder Cancer AJCC v8Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8Stage IV Distal Bile Duct Cancer AJCC v8Stage IV Gallbladder Cancer AJCC v8Stage IV Intrahepatic Cholangiocarcinoma AJCC v8Stage IVA Gallbladder Cancer AJCC v8Stage IVB Gallbladder Cancer AJCC v8Unresectable Extrahepatic Bile Duct CarcinomaUnresectable Gallbladder CarcinomaUnresectable Intrahepatic Cholangiocarcinoma
NCT03768414SWOG Cancer Research Network452
招募中
2 期
Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic CancerResectable Pancreatic Adenocarcinoma
NCT06423326Emory University36
招募中
不适用
Randomized Phase 3 Trial Comparing Upfront Surgery versus Neoadjuvant modified FOLFIRINOX in Patients with Resectable Pancreatic Cancer
KCT0007327Asan Medical Center314
Unknown
3 期
Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown PrimaryCarcinoma
NCT00126269Gustave Roussy, Cancer Campus, Grand Paris192
Randomized Phase III Trial of Surgery Alone or... | 临床试验